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ABSTRACT It is now possible to construct genome-scale metabolic networks for particular microorganisms. Extreme pathway
analysis is a useful method for analyzing the phenotypic capabilities of these networks. Many extreme pathways are needed to
fully describe the functional capabilities of genome-scale metabolic networks, and therefore, a need exists to develop methods
to study these large sets of extreme pathways. Singular value decomposition (SVD) of matrices of extreme pathways was used
to develop a conceptual framework for the interpretation of large sets of extreme pathways and the steady-state ﬂux solution
space they deﬁne. The key results of this study were: 1), convex steady-state solution cones describing the potential functions
of biochemical networks can be studied using the modes generated by SVD; 2), Helicobacter pylori has a more rigid metabolic
network (i.e., a lower dimensional solution space and a more dominant ﬁrst singular value) than Haemophilus inﬂuenzae for the
production of amino acids; and 3), SVD allows for direct comparison of different solution cones resulting from the production of
different amino acids. SVD was used to identify key network branch points that may identify key control points for regulation.
Therefore, SVD of matrices of extreme pathways has proved to be a useful method for analyzing the steady-state solution
space of genome-scale metabolic networks.
INTRODUCTION
There has been intense effort and investment in sequencing
and annotating the genomes of an increasing number of
organisms (Drell, 2002). Genome research has provided the
scientific community with an invaluable ‘‘parts catalog’’ for
cells. This parts catalog leads to the construction of genome-
scale networks (Covert et al., 2001; Edwards and Palsson,
1999; Schilling et al., 2002; Schilling and Palsson, 2000),
which substantiates the need for integrative analysis.
Extreme pathway analysis has emerged as a useful
approach for analyzing systemic features of reconstructed
networks (Papin et al., 2002a; Price et al., 2002a; Schilling
and Palsson, 2000; Wiback and Palsson, 2002). This analysis
approach generates a unique and conically independent set of
vectors called extreme pathways. Extreme pathways form the
convex basis for the steady-state solution space. All possible
steady-state flux distributions through the metabolic network
are nonnegative linear combinations of the extreme pathways,
thus forming a solution space that is a convex cone and whose
edges are the extreme pathways (Fig. 1). This cone sits in
a high-dimensional space, termed the flux space, where each
axis corresponds to a flux through a reaction in the network.
Analyzing these high-dimensional solution cones has pro-
vided insight into the integrated functions of metabolic
networks (Papin et al., 2002a,b; Price et al., 2002a).
The calculation of extreme pathways for increasingly
large networks is computationally intensive (Samatova et al.,
2002) and results in the generation of large data sets (Papin
et al., 2002a; Price et al., 2002a). Even for integrated geno-
me-scale models of microbes under simple conditions
(minimal medium and the production of individual amino
acids), extreme pathway analysis can generate thousands of
vectors. These large sets of extreme pathways have been
statistically analyzed and network properties have been
identified (Papin et al., 2002a,b; Price et al., 2002a). For
example, it has been shown that for the production of the
amino acids, the metabolic network of Haemophilus
inﬂuenzae has an order of magnitude larger degree of
pathway redundancy than the metabolic network of
Helicobacter pylori, meaning that in general there are far
more systemically independent pathways in H. inﬂuenzae
leading to the production of an amino acid (Papin et al.,
2002a; Price et al., 2002a). It has also been found that the
number of reactions that participate in the extreme pathways
that produce a particular product is poorly correlated to the
product yield and the molecular complexity of the product.
Reaction sets that always appear together in any steady-state
solution have also been identified with extreme pathway
analysis generating hypotheses about systemic regulation
(Papin et al., 2002b).
Other network-based analysis methods have been utilized
to study metabolic networks. Elementary modes analysis
(Schuster et al., 2000), a very similar pathway analysis
technique, has been successfully used to identify optimal
poly-b-hydroxybutyrate yields in Saccharomyces cerevisiae
(Carlson et al., 2002), and to identify optimal aromatic
amino acid yields in Escherichia coli (Liao et al., 1996).
These analyses then guided the development of E. coli
strains that attained these high yield values. All of the
analyses described above for the extreme pathways are
equally applicable to the elementary modes. In addition,
other approaches for modeling biological systems have
yielded for important results, including metabolic control
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analysis (Fell, 1996), kinetic theory (Reich and Sel’kov,
1981; Heinrich and Schuster, 1996), and flux balance
analysis (Varma and Palsson, 2002; Bonarius et al., 1997;
Edwards et al., 1999). Taken together, these results represent
emergent properties of reconstructed metabolic networks
that can only be calculated from such integrative techniques.
Inasmuch as the set of extreme pathways for metabolic
networks is generally very large, it canbe a challenge to extract
all the relevant information from these calculations. General
methods are now needed to extract such information, as well
as reduce the dimensionality of the data sets to facilitate
physiological characterizations. Singular value decomposi-
tion (SVD) is a well-developed method for extracting
dominant features of large data sets and for reducing the
dimensionality of the data. SVD has been used for analyzing
microarray data (Alter et al., 2000) and predicting regulatory
networks (Yeung et al., 2002), as well as for diverse ap-
plications such as data compression and image processing.
Recently, SVD analysis has been used to extract systemic
reactions and key functions from the stoichiometry of
metabolic networks (Famili andPalsson, unpublished results).
SVD of stoichiometric matrices reveal key chemical trans-
formations of the respective metabolic networks.
The work presented herein is a novel approach for using
SVD analysis to describe the solution space of metabolic
networks. It will be shown that the first mode of the SVD
corresponds to a valid biochemical pathway that is mass
balanced and does not violate reaction directionality. This
first mode represents a center line of the allowable solution
space of the metabolic network. The subsequent modes will
be shown to correspond to important directions in the
solution space that, if regulated, would best control the
phenotypic potential of the metabolic network.
MATERIALS AND METHODS
Calculation of the extreme pathway matrix
An m 3 n stoichiometric matrix, S, was constructed relating m metabolites
to n reactions (Edwards and Palsson, 1999; Schilling et al., 2002; Schilling
and Palsson, 2000). Each column in the matrix corresponded to either
a metabolic reaction or a transport process, with the elements in the column
representing the reaction stoichiometry. Internal fluxes corresponded to the
movement of mass through a reaction within the system, whereas exchange
fluxes transferred mass across a system boundary. Assuming steady state,
mass balances around each metabolite were written as
S  v ¼ 0; (1)
where v is a vector of fluxes for the n reactions in the network.
The defined reversibility or irreversibility of an internal reaction placed
thermodynamic constraints on the network. These constraints were applied
by decoupling reversible reactions into a forward and a reverse reaction, and
constraining all fluxes to be greater than or equal to zero.
vi$ 0; 8i: (2)
Using Eqs. 1 and 2, a set of convex basis vectors that do not violate
thermodynamic constraints was generated. The basis vectors for this convex
space, called extreme pathways, represent a unique and minimal set of
vectors that spans the solution space (Schilling et al., 2000). Any point in the
steady-state solution space can then be written as a nonnegative linear
combination of the extreme pathways, forming a cone (Eq. 3).
C ¼ fv : v ¼ +ai pi;ai$ 0; 8ig: (3)
C is the convex cone formed by the extreme pathways (pi) and for which
any feasible steady-state flux distribution (v) can be written as a weighted
linear combination of the extreme pathways, where ai is the weight for each
extreme pathway. A detailed algorithm for calculating the extreme pathways
has previously been described (Schilling et al., 2000).
The extreme pathway matrix, P, was formed with all of the extreme
pathways, pi, as columns and the reactions as rows, where the elements in
a column represent the usage of reactions in the corresponding extreme
pathway. Because all reversible reactions were decoupled into two different
reactions, only nonnegative values were contained in the extreme pathway
matrix. Thus, the convex solution space spanned by the extreme pathways
must lie in the positive orthant of the flux space. Extreme pathways that do
not utilize any exchange fluxes were excluded from the extreme pathway
matrix because they are thermodynamically infeasible (Beard et al., 2002;
Price et al., 2002b).
Each extreme pathway was normalized to unit length before the SVDwas
calculated. Normalization was performed because the extreme pathways can
be arbitrarily scaled. By normalizing all extreme pathways to unit length,
equal weighting was given to each extreme pathway when calculating the
SVD. An alternative way to normalize pi is to use the limiting vmax in the
pathway, if such values are known.
Extreme pathways of H. inﬂuenzae and H. pylori
Extreme pathway matrices were previously calculated for the production of
different individual amino acids using genome-scale stoichiometric matrices
for H. pylori (Price et al., 2002a) and H. inﬂuenzae (Papin et al., 2002a).
These extreme pathway matrices were analyzed using the SVD methods
detailed below. For H. pylori, the extreme pathway matrices used in this
FIGURE 1 Schematic of a biochemical re-
action network and its convex, steady-state
solution cone. Extreme pathway analysis gen-
erates a set of vectors that define a convex
solution space. This solution space circum-
scribes all possible flux distributions, thus the
phenotypes, of the biochemical reaction net-
work.
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study were calculated with the following outputs: a single nonessential
amino acid (asparagine, aspartic acid, cysteine, glutamine, glutamic acid,
glycine, lysine, proline, serine, threonine, tryptophan, or tyrosine),
succinate, acetate, formate, lactate, ammonia, and carbon dioxide. For H.
inﬂuenzae, the extreme pathway matrices were calculated with the following
outputs: acetate, carbon dioxide, and a single nonessential amino acid
(alanine, asparagine, aspartic acid, glutamine, glycine, histidine, isoleucine,
leucine, lysine, methionine, phenylalanine, proline, serine, threonine,
tryptophan, tyrosine, or valine). The only allowable inputs for both
organisms were constituents of the respective minimal medium (Edwards
and Palsson, 1999; Schilling et al., 2002; Schilling and Palsson, 2000). For
H. inﬂuenzae these inputs were: fructose, glutamic acid, ammonia, oxygen,
arginine, cysteine, heme, NAD, phosphate, panthoenate, putrescine,
spermidine, thiamin, and uracil. For H. pylori the allowable inputs were:
alanine, arginine, adenine, phosphate, sulfate, oxygen, histidine, isoleucine,
leucine, methionine, phenylalanine, valine, and thiamin.
Singular value decomposition
For a given extreme pathway matrix P 2 Rnxp, SVD decomposes the
extreme pathway matrix into three matrices,
P ¼ U S 0
0 0
 
nxp
V T; (4)
where U 2 Rnxn is an orthonormal matrix of the left singular vectors (as
columns in U), V 2 Rpxp is an analogous orthonormal matrix of the right
singular vectors, and S 2 Rrxr is a diagonal matrix containing the singular
values si;
S ¼ diagðs1;s2; . . . ;srÞ; where r ¼ rankðPÞ: (5)
The diagonal elements of S are arranged in descending order such that
s1 $ s2 $ . . . $ sr[ 0. The first r columns of U and V, referred to as the
left and right singular vectors, or modes, are unique and form the
orthonormal basis for the column space and row space of P, respectively.
The singular values are the square roots of the eigenvalues of PTP (Lay,
1997). The magnitude of the singular values in S indicate the relative con-
tribution of the singular vectors of U and V in reconstructing the P matrix.
The second singular vector thus contributes less to the construction of P than
the first singular vector, and its relative contribution can be assessed by the
magnitude of its singular value compared to other singular values. All SVD
calculations were performed using MATLAB (Mathworks, Natick, MA).
The fractional singular values were calculated by dividing each si by the
sum of all singular values. The cumulative fractional contribution is defined
as the sum of the first n fractional singular values, where n can vary from 1 to
r. Note that ‘‘singular vector’’ and ‘‘mode’’ are used interchangeably in this
manuscript. The columns of U can be called ‘‘eigenpathways’’ and the rows
of VT can be called ‘‘eigenparticipations’’ (Fig. 2). The eigenparticipations
(Fig. 2), or the modes of V, represent how the extreme pathways can be
linearly combined to form the scaled modes of U, as illustrated in Eq. 6.
P  V ¼ S  U: (6)
V gives the weightings on the pathways needed to reconstruct each of the
modes of U as scaled by their respective singular values. P can be thought of
as a matrix that operates upon a unit sphere, V, to form an ellipse that is
elongated along each singular vector of U in proportion to the corresponding
singular value in S (Lay, 1997). The modes referred to throughout this
manuscript are the columns of U, or eigenpathways.
Extreme pathway decomposition
Each extreme pathway can be described as a weighted (positive or negative)
linear combination of the first r modes of U, where r is the rank of P.
Because the modes are orthonormal to each other, the weighting for each
mode was found by taking the dot product of an extreme pathway with
a given mode of U. The modal spectrum (or the set of r weightings) was
calculated in this manner and gave insight into which mode is most
important for constructing a particular extreme pathway.
CONCEPTUAL FRAMEWORK
Interpretation of the ﬁrst mode
Computing the SVD of a convex basis for a solution space
that lies within the positive orthant of the flux space ensures
that the first mode must lie within the solution cone. In terms
of the solution space of metabolic networks, this means that
the first mode corresponds to a valid biochemical pathway
through the network (i.e., mass balance and thermodynamic
constraints are obeyed).
In general, the first mode, or first eigenpathway is directed
down the middle of the space spanned by the extreme
pathways (Fig. 3A). In a symmetric cone, thefirstmodewould
come up through the geometric center of the cone (Fig. 3 B).
However, if the cone is asymmetric, the first mode will be
pulled more closely toward those portions of the cone with
higher extreme pathway density. Portions of the extreme
pathway cone that contain a high density of extreme pathways
form ‘‘soft edges’’ and represent many systemically in-
dependent flux distributions that yield similar metabolic
phenotypes. Thus, fluxes that are common in the extreme
pathwayswill be reflectedmore heavily in the dominantmode
of the cone. It should also be noted that the lengths of the
extreme pathways can alter the direction of the first mode,
wherea longer extremepathwaywill pull thefirstmode toward
itself. In this study, however, all extreme pathways have unit
length since the necessary vmax data is not available.
Interpretation of subsequent modes
Each subsequent mode (or eigenpathway) after the first
describes the direction of most variance in the subspace that is
orthogonal to the previous modes. For example, the second
mode describes the next direction in which most of the
variance can be explained, and is orthogonal to the first mode.
Fig. 3C schematically demonstrates how the first threemodes
can characterize the solution space defined by the extreme
pathways. Because each of the subsequent modes must be
orthogonal to the first mode, they describe the cross section of
the cone orthogonal to the dominant mode. Thus, in the three-
dimensional case, the first mode defines the plane in which
the second and third modes must lie. The second mode
characterizes the direction that captures the most variance in
this plane, and is the line with the minimum sum of squared
differences between the line and all the extreme pathways.
Thus, the direction of themode is influenced by both thewidth
of the cone in a particular direction and by the number
of extreme pathways that are closely aligned along that
direction. Thus, it can correspond to either the widest region
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of a cone (Fig. 3 C), or to a region that has a high extreme
pathway density (Fig. 3 D). Because each of the modes is
a linear combination of the extreme pathways, each mode
satisfies the mass balance constraints. However, in contrast to
the first mode, the subsequent modes individually will not
necessarily satisfy reaction directionality constraints.
These subsequent modes represent important directions in
the cone. For example, in Fig. 3 C, if extreme pathway 1
(EP1) were the desired state, then the second principal mode
could represent a critical regulatory modality. Movement of
the solution from the flux distribution corresponding to the
first mode to the desired state would be accomplished by
moving in the direction defined by the second mode.
Similarly, if extreme pathway 2 (EP2) represented the
desired state, then movement along the third principal mode
would lead from the flux distribution corresponding to the
first mode to the desired flux distribution. Moving a solution
along a mode thus represents desired systemic regulatory
control of the corresponding flux values.
Special case: subsets of orthogonal
extreme pathways
Although the extreme pathways are not generally orthogonal
to each other, it is possible in certain cases to have an extreme
pathway or a subset of extreme pathways that are orthogonal
to the rest. SVD of a cone containing extreme pathways that
are orthogonal can generate modes that are identical to, or
combinations of, these orthogonal pathways. Consequently,
these components may not be represented in the first mode,
inasmuch as they are decoupled from the rest of the extreme
pathways. Although in general the first mode will involve the
use of every flux used in any extreme pathway, it may not
include fluxes that are only used in extreme pathways that are
orthogonal to all other extreme pathways.
Interpretation of singular values
The singular values of the extreme pathway matrix charac-
terize the amount of variance described by the directions of
the corresponding modes. Large singular values indicate that
a high degree of variance is captured in the direction of the
corresponding mode. A large first fractional singular value
means that the extreme pathways lie, on average, closer to the
first mode in comparison to evenly distributed fractional
singular values, which indicate that the extreme pathways are,
on average, farther from the first mode.
SVD analysis of simple reaction networks
SVD of extreme pathway matrices of simple reaction
networks demonstrated how important characterizations
FIGURE 2 The singular value decomposition of the extreme pathway matrix.
FIGURE 3 Conceptual framework for application of singular value
decomposition to extreme pathway analysis. In panel A, a convex
representation of the cone defined by the extreme pathways is illustrated.
The first mode from SVD analysis represents the principal direction of the
cone. In panel B, the effect of symmetry of the convex cone is demonstrated.
The areas shown represent cross sections of the multidimensional cone. The
extreme pathways are represented by gray circles on the edges of the cone.
The first mode is represented by a black circle inside the space. With ‘‘soft
edges’’ in a cone, the dominant mode is ‘‘pulled’’ toward this region of the
space. In panel C, we can see how the second and third principal modes
characterize the convex cone. In the plane perpendicular to the first mode,
the second and third modes characterize the variance in mutually
perpendicular directions. Movement along the second mode allows for the
most control of the space characterized by the first mode. In panel D, the
effect of ‘‘soft edges’’ on the directions of the second and third mode is
demonstrated.
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about the function of metabolic networks could be gained
from this type of analysis. The system in Fig. 4 A is a simple
linear chain of reactions. For this case, only one extreme
pathway exists. The solution space is a degenerate cone; it is
simply a line in the six-dimensional space characterized by the
six fluxes. Thus, only one singular value exists and the first
mode captures all of the variance of the one-dimensional
solution space. This very simple case shows how a high first
fractional singular value (in this case 1 or 100%) is a measure
of how well the dominant mode represents the system. At
100%, the dominant mode represents the entire cone, because
the cone is in fact this very line. Once one flux is set to
a particular value, the values for all the other fluxes are fixed.
A slightly more complex example system demonstrates
how the SVD describes flux variability allowed within the
cone. The system in Fig. 4 B is defined by eight fluxes and
four extreme pathways. However, the solution cone itself is
a three-dimensional object, and thus there are three singular
values. The first mode captures 47% of the variance. The
second and third modes account for 28% and 22% of the
variance, respectively. Because there are multiple modes,
flexibility exists in the allowable ratios between the flux
values.
Fig. 4C shows a reaction network that is similar to the one
in Fig. 4 B, but that contains one additional exchange flux.
For the extreme pathway matrix of this system, there are four
singular values, indicating a four-dimensional cone residing
in the nine-dimensional flux space. The first, second, third,
and fourth modes account for 39%, 22%, 20%, and 19% of
the variance in the system, respectively. In Fig. 4 B, if the
reaction that converts metabolite B to C is active, then the
reaction that converts C to D is active, or the reaction that
converts C to E is active, or both are active. However, this is
not the case for the system in Fig. 4 C; there is the additional
exchange flux for metabolite C. Thus, a wider range of
steady-state solutions is available to the network.
The importance of the modes subsequent to the first is
evident in Fig. 4, B andC. These subsequent modes illustrate
important tradeoffs in the network where flux levels can be
increased or decreased to change the steady-state flux
distribution through the network. These tradeoffs in the
metabolic network correspond to movement along the line
described by the mode in the flux solution space. In the
figure, the changes in the numerical value for fluxes shown in
black are opposite to that of the fluxes shown in gray. Thus,
if a black flux increases, a gray flux decreases, or vice versa.
The second mode in panel B illustrates that for a given state
of the network, if the reaction that converts C to D is
increased, the reaction that converts C to E is decreased. This
shift would move the solution point from a balanced D and E
secretion (as seen in the first mode) to one that gives more
weight to the secretion of D over E. In Fig. 4 B, the third
FIGURE 4 Singular value decomposition of
sample reaction networks. The SVD of these
three reaction networks demonstrates how the
SVD characterizes general properties of the
solution cone, defining the phenotypic possi-
bilities of the metabolic networks. In panel A,
we have the simplest case—the linear chain of
reactions has simply one extreme pathway, and
consequently the first mode characterizes
100% of the extreme pathway matrix. This
cone can be visualized as a simple vector, the
‘‘narrowest’’ possible case. In panel B, the
system has four extreme pathways. Its first
mode characterizes 47% of the total solution
space. In panel C, the system has six extreme
pathways. The first mode characterizes only
39% of the system. The first modes represent
valid biochemical pathways in the network.
The black and gray arrows in subsequent
modes represent increased and decreased flux
levels, respectively. The widths of all of the
arrows in the representations of the modes are
proportional to the flux through the corre-
sponding reaction.
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mode illustrates a split at metabolite B. The exchange flux for
metabolite A and the reaction that converts A to B are gray.
The exchange flux for metabolite B and the fluxes for all
subsequent processing reactions are black. The subsequent
modes thus represent key branch points in the network and
how they influence the flux distribution.
Similar tradeoffs can be seen in Fig. 4 C. In the second
mode, the black fluxes involve the input of metabolite B, the
conversion of B to C, and the output of C. All other fluxes are
gray. If black is chosen to represent a flux increase with
respect to the first mode, then B will be consumed and
converted to C at a higher rate, whereas the consumption of
A will decrease as well as the production of D and E. In the
third mode, there is a split between the conversion of C to D
or E (similar to that seen in the second mode of Fig. 4 B). In
the fourth mode, one branch point is the production of C over
the production of D and E.
Each of these subsequent modes obeys mass balance
constraints, i.e., the magnitude of the increases in the fluxes
out of a metabolite equals the magnitude of the fluxes that
increase going into the metabolite. Consequently, in the
second mode of Fig. 4 B and the third mode of Fig. 4 C, the
black flux that leavesmetaboliteC has a value that is equal and
opposite the gray flux that leavesmetabolite C. This effect can
also be seen in the fluxes around metabolite C in the fourth
mode of Fig. 4C. The black exchange flux leaving metabolite
C is equal in magnitude to the sum of the black flux entering
and the negative of the two gray fluxes leaving.
These sample systems illustrate how the SVD framework
presented herein can elucidate systemic tradeoffs at key
branch points in metabolic networks. Systemic tradeoffs
represent critical decision points that affect what state the
system can achieve and thus have relevance to regulation of
the network. For instance, in the second mode of Fig. 4 B and
the third mode of Fig. 4 C, metabolite C is a critical decision
point where the output flux for D and the output flux for E
can be changed.
RESULTS
SVD was applied to the extreme pathway matrices pre-
viously calculated for amino acid production in H.
inﬂuenzae and H. pylori (Papin et al., 2002a; Price et al.,
2002a). Briefly, the extreme pathway matrices were
calculated for the synthesis of each of the nonessential
amino acids of the two organisms. There are 17 nonessential
amino acids in H. inﬂuenzae (alanine, asparagine, aspartic
acid, glutamine, glycine, histidine, isoleucine, leucine,
lysine, methionine, phenylalanine, proline, serine, threonine,
tryptophan, tyrosine, and valine) and 12 in H. pylori
(asparagine, aspartic acid, cysteine, glutamine, glutamatic
acid, glycine, lysine, proline, serine, threonine, tryptophan,
and tyrosine). Thus, a total of 29 extreme pathway matrices
were studied. A list of the number of extreme pathways for
each condition can be found in Fig. 5.
Singular values
The cumulative fractional contributions of the singular values
(reported as a percent) are shown in Fig. 5. Each curve
represents the cumulative fractional contribution of themodes
to the extreme pathway matrix associated with a particular
amino acid. For H. inﬂuenzae, the 17 curves (one for each
nonessential amino acid) are shown in gray; For H. pylori,
the 12 curves (one for each nonessential amino acid) are
represented in black (see Fig. 5). The cumulative fractional
contributions for the amino acids tightly cluster according to
the respective organism. The difference between the average
first fractional singular value and the average second
fractional singular value in H. pylori is 0.20. The same
difference in H. inﬂuenzae is 0.09. The effect of this
difference can be seen in Fig. 5, where the cumulative
fractional contribution increases faster for H. pylori than for
H. inﬂuenzae. These results indicate a more even distribution
of singular values in H. inﬂuenzae than in H. pylori.
Effective dimensionality
The rank of each of the extreme pathway matrices for amino
acid production in H. pylori and H. inﬂuenzae was
calculated. The number of singular values needed to
characterize 95% of the variance (Scrit) was also evaluated
(Fig. 5). The average rank for H. pylori extreme pathway
matrices was 45, meaning that the convex space can be
completely described by an average of 45 modes. However,
95% of the variance can be described by just the first 18
modes. Interestingly, even though H. inﬂuenzae had
a smaller average rank (38) than H. pylori (45), more
modes were needed in H. inﬂuenzae (between 22 and 24)
than in H. pylori (18) to describe 95% of the variance. The
effective dimensionality of the solution spaces (defined by
a stringent 95% cutoff) was around one-half of the rank for
both organisms.
Comparing dominant modes
Because the first mode best describes the variance of the
entire cone, comparing the first modes of different extreme
pathway matrices is a way to compare the direction of the
two corresponding cones. The dominant modes of the
extreme pathway matrices associated with the production of
different amino acids were compared by calculating the
angles between the modes for both H. pylori and H.
inﬂuenzae. Dominant modes that lie in a similar direction
(i.e., a small angle between modes) indicate that the principal
utilization of the metabolic network is similar when
achieving the different objectives. The angles between the
first modes for the 17 amino acids in H. inﬂuenzae can be
found in Table 1. The three smallest and the three largest
pairs of angles were underlined and bold faced respectively.
The three smallest pairs of angles were for tyrosine and
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phenylalanine (2.98), asparagine and aspartic acid (3.88), and
serine and glycine (4.68). The synthesis of tyrosine and
phenylalanine differ by only a few final processing steps,
explaining the proximity of their dominant modes. The three
largest pairs of angles are for leucine and proline (25.18),
alanine and proline (22.48), and leucine and threonine
(22.18). The angles between the second and third modes were
also calculated, and the average angles are shown in Table 1.
When analyzing the first, second, and third modes, alanine
consistently had a high average angle in comparison to the
other amino acids, which indicates that the convex solution
cone for alanine production is the most distinct in the
multidimensional space.
Similar calculations were done for the set of extreme
pathways for H. pylori amino acid synthesis (Table 2). The
three smallest pairs for the first modes in the H. pylori
extreme pathway matrices were serine and glycine (3.78),
glutamine and glutamatic acid (3.88), and tyrosine and
cysteine (3.98). The three largest pairs were aspartic acid and
proline (15.78), asparagine and proline (14.98), and glycine
and proline (14.68). The average angles between the first,
second, and third modes are also indicated in Table 2.
The relative proximity of the first modes tends to coincide
with the biochemical precursors from which the individual
amino acids are derived. The three largest angles between the
first modes for the analyzed data sets inH. inﬂuenzae andH.
pylori correspond to pairs of amino acids that are derived
from different central metabolic precursors. For example, the
largest angle in theH. inﬂuenzae data set is between the first
modes corresponding to proline and leucine; proline is
derived from a-ketoglutarate whereas leucine comes from
pyruvate. In contrast, the three closest pairs in each case
occur between amino acids that stem from the same
precursor; the only exception is for cysteine and tyrosine
in H. pylori. Examination of the first modes from these two
extreme pathway sets shows that they both have higher
fluxes through reactions involved in oxygen consumption, as
compared to the first mode for tryptophan (which has a larger
angle but is synthesized from the same precursor as
tyrosine). This result indicates that the systemic production
of cysteine and tyrosine consumes more oxygen then the
systemic production of tryptophan in H. pylori. Thus, the
angles between the first modes can be influenced by systemic
considerations that are not evident based solely upon the
identification of the key precursor in central metabolism.
Subsequent modes
The extreme pathways associated with histidine and alanine
synthesis in H. inﬂuenzae were further analyzed to help
identify possible control points in some of the subsequent
modes. First, the extreme pathways that correspond to
maximum histidine and alanine yield in H. inﬂuenzae were
decomposed to ascertain the weightings for each of the
modes that were necessary to reconstruct each pathway.
There were 18 extreme pathways (out of 4934) with the
maximum alanine yield and 64 extreme pathways (out of
4702) with the maximum histidine yield.
In Fig. 6, A and C, the extreme pathway decompositions
are shown, with the weightings for each mode given on the y
axis. Each line represents the modal spectrum for one ex-
treme pathway. The modes with the maximum contribution
FIGURE 5 Cumulative frac-
tional contributions for the singular
value decompositions of the ex-
treme pathway matrices in H.
inﬂuenzae and H. pylori. The
cumulative fractional contribution
is defined as the sum of the first n
fractional singular values (reported
as a percent). This value represents
the contribution of the first n modes
to the overall description of the
system. The rank of the respective
extreme pathway matrix is shown
for nonessential amino acids. The
Scrit value is the number of singular
values that account for$95% of the
variance in the matrices. Entries
with ‘‘- - -’’ correspond to essential
amino acids.
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to alanine or histidine production were determined by multi-
plying the mode’s alanine or histidine exchange flux by the
mode’s weight.
For the alanine extreme pathway decomposition, mode 2
had the largest contribution to the net alanine production.
This mode was inspected, and one branch point in the central
metabolic network is indicated in Fig. 6 B. This branch point
demonstrated an increase in the glycolytic flux that leads to
the synthesis of pyruvate, a key precursor to alanine, and
a decrease in the flux leading to the pentose phosphate
reactions.
In the modal spectrum of the 64 extreme pathways with
maximum histidine yield, mode 11 had the most significant
contribution to a change in histidine flux. One branch point
in this mode is indicated in Fig. 6 D. This branch point shifts
flux from the pentose phosphate reactions (indicated in gray)
to the reactions catalyzed by the rpiA and prsA gene
products that lead to the synthesis of PRPP (phosphoribosyl
TABLE 1 Angles between the ﬁrst dominant modes of the extreme pathway matrices for amino acid synthesis in H. inﬂuenzae
ALA ASN ASP GLN GLY HIS ILE LEU LYS MET PHE PRO SER THR TRP TYR VAL
ALA 0.0 – – – – – – – – – – – – – – – –
ASN 14.9 0.0 – – – – – – – – – – – – – – –
ASP 14.6 3.8 0.0 – – – – – – – – – – – – – –
GLN 16.8 7.9 9.0 0.0 – – – – – – – – – – – – –
GLY 16.6 6.0 7.1 8.1 0.0 – – – – – – – – – – – –
HIS 17.6 9.0 10.9 11.5 11.2 0.0 – – – – – – – – – – –
ILE 15.0 11.2 10.4 14.2 13.7 16.0 0.0 – – – – – – – – – –
LEU 18.8 19.2 19.8 20.4 19.5 19.2 19.7 0.0 – – – – – – – – –
LYS 13.3 9.6 9.0 12.6 12.4 14.2 7.9 18.6 0.0 – – – – – – – –
MET 17.7 11.5 10.7 14.4 13.4 16.2 8.6 21.8 10.0 0.0 – – – – – – –
PHE 15.6 7.1 7.2 10.8 10.0 11.0 10.0 18.4 9.4 10.6 0.0 – – – – – –
PRO 22.4 16.9 17.1 16.7 18.2 20.0 14.8 25.1 16.1 14.6 15.7 0.0 – – – – –
SER 15.3 4.7 5.6 7.9 4.6 10.2 12.0 18.8 10.7 11.9 8.2 17.1 0.0 – – – –
THR 15.7 11.1 9.9 14.4 14.3 16.2 6.6 22.1 8.4 8.9 10.7 16.0 12.5 0.0 – – –
TRP 16.7 8.1 8.9 11.6 11.5 8.9 12.0 19.1 11.1 12.4 5.5 16.8 9.4 12.3 0.0 – –
TYR 15.6 6.4 6.6 10.2 9.2 10.5 10.5 18.2 9.6 11.0 2.9 16.1 7.4 11.1 5.6 0.0 –
VAL 13.5 13.0 13.0 15.0 14.4 15.9 12.1 13.3 11.2 14.7 12.2 18.8 13.1 14.2 13.8 12.3 0.0
M1 16.3 10.0 10.2 12.6 11.9 13.7 12.2 19.5 11.5 13.0 10.3 17.6 10.6 12.8 11.5 10.2 13.8
M2 80.5 18.5 19.3 23.1 22.7 38.8 18.9 39.3 18.6 19.6 18.4 30.9 19.5 21.5 24.1 18.5 24.0
M3 76.7 35.5 35.0 40.8 39.2 47.8 52.1 49.2 56.0 48.9 34.9 56.3 35.8 61.8 39.0 35.0 62.6
The amino acids are represented by their three-letter abbreviation. The angles are in degrees. Also note that the matrix is symmetric, and consequently only
half of the values are shown. The lowest angles between the first modes of the extreme pathway matrices for the production of the individual amino acids are
underlined. The largest angles between the first modes are shown in boldface type. The row M1 corresponds to the average angle between the first mode of
the extreme pathway matrix for the indicated amino acid and all of the other data sets. The row M2 corresponds to the average angle between the second
modes. The row M3 corresponds to the average angle for the third mode.
TABLE 2 Angles between the ﬁrst dominant modes of the extreme pathway matrices for amino acid synthesis in H. pylori
ASN ASP CYS GLN GLU GLY LYS PRO SER THR TRP TYR
ASN 0.0 – – – – – – – – – – –
ASP 4.0 0.0 – – – – – – – – – –
CYS 7.8 9.2 0.0 – – – – – – – – –
GLN 5.6 6.1 8.8 0.0 – – – – – – – –
GLU 6.3 6.7 8.1 3.8 0.0 – – – – – – –
GLY 5.3 6.0 8.2 6.0 6.5 0.0 – – – – – –
LYS 8.0 9.0 5.9 8.1 7.3 8.8 0.0 – – – – –
PRO 14.9 15.7 11.3 13.0 11.4 14.6 10.9 0.0 – – – –
SER 4.7 5.7 6.5 5.3 5.6 3.7 7.2 13.3 0.0 – – –
THR 5.7 6.6 5.4 6.9 6.5 6.9 5.4 12.2 5.4 0.0 – –
TRP 9.4 10.7 6.0 10.8 10.3 9.5 9.0 14.0 8.3 8.2 0.0 –
TYR 8.1 9.3 3.9 9.2 8.4 8.2 6.5 11.7 6.6 6.0 4.5 0.0
M1 7.2 8.1 7.4 7.6 7.4 7.6 7.8 13.0 6.6 6.8 9.2 7.5
M2 28.8 26.5 29.4 24.9 25.3 22.3 29.0 52.4 22.2 23.7 53.4 31.0
M3 33.7 35.7 40.8 33.1 31.7 32.1 35.5 64.2 29.8 30.8 48.0 36.8
The amino acids are represented by their three-letter abbreviation. The angles are in degrees. Also note that the matrix is symmetric and consequently only
half of the values are shown. The lowest angles between the first modes of the extreme pathway matrices for the production of the individual amino acids are
underlined. The largest angles between the first modes are shown in boldface type. The row M1 corresponds to the average angle between the first mode of
the extreme pathway matrix for the indicated amino acid and all of the other data sets. The row M2 corresponds to the average angle between the second
modes. The row M3 corresponds to the average angle for the third mode.
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pyrophosphate), a key precursor of histidine. Other branch
points were present within the mode but are not shown.
DISCUSSION
This study presents the application of SVD to the analysis of
large sets of extreme pathways generated from analysis of
genome-scale metabolic networks. SVD of extreme pathway
matrices has led to the following key results: 1), Convex
steady-state solution cones characterizing the potential
functions of biochemical networks were described using
the modes generated by SVD, as readily illustrated by
representative example systems; 2), SVD of extreme
pathway matrices characterizing amino acid synthesis
demonstrated that H. pylori has a more ‘‘rigid’’ metabolic
network (lower effective dimensionality and more dominant
first singular value). This interpretation is consistent with
previously published results (Price et al., 2002a); and 3),
SVD allowed for the comparison of different solution cones
corresponding to the production of different amino acids
within a genome-scale metabolic network.
Extreme pathways define a convex cone in a high-
dimensional flux space that can be difficult to interpret and
understand. The value of understanding the solution cone lies
in its circumspection of all possible metabolic phenotypes
available to a given network. SVD of extreme pathways gives
several important measures that characterize these cones.
First, the singular values can give ameasure of the distribution
of variance within the solution cone. Amore even distribution
of the contribution of the singular values is indicative of a cone
that has wide variability with respect to its modes. Another
important feature can be seen in the interpretation of the first
mode; the first mode is a valid pathway through the network.
With the exception of orthogonal extreme pathways (as was
FIGURE 6 Key branch points in H. inﬂuenzae metabolic network for the synthesis of alanine and histidine. In panel A, there are 18 extreme pathways
represented, each with the maximum yield of alanine. A key branch point in mode 2 of the metabolic network for alanine synthesis is shown in panel B. In panel
C, there are 64 extreme pathways represented, each with the maximum histidine yield. A key branch point in mode 11 of the metabolic network for histidine
synthesis is shown in panel D. Black and gray fluxes change in opposite directions. Dashed lines correspond to reactions not shown. Indicated metabolites are
the following: E4P, erythrose 4-phosphate; F6P, fructose 6-phosphate; FDP, fructose-1,6-diphosphate; FRU, fructose; OA, oxaloacetate; PRPP,
phosphoribosyl pyrophosphate; PYR, pyruvate; R5P, ribose 5-phosphate; RL5P, D-ribulose 5-phosphate; S7P, sedo-heptulose 7-phosphate; T3P1,
glyceraldehyde 3-phosphate; T3P2, dihydroxyacetone phosphate; X5P, D-xylulose-5-phosphate. Reactions are catalyzed by the following enzymes: fba,
fructose-1,6-bisphosphatate aldolase; fbp, fructose-1,6-bisphosphatase; pfkA, phosphofructokinase; prsA, phosphoribosyl pyrophosphate synthase; rpiA,
ribose-5-phosphate isomerase A; talB, transaldolase B; tktA, transketolase; tpi, triosphophate isomerase.
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previously discussed), the first mode can be visualized as
a single vector that characterizes the general direction of the
cone. These features give very specific quantitative measures
of the systemic capabilities of a network. It is important to
note that SVD characterizes the linear, rather than the convex,
space defined by the extreme pathways. Thus, the modes
characterize a space that includes the complete solution space,
but also span an additional space that is infeasible due to
thermodynamic constraints. Therefore, not all combinations
of the modes yield valid solutions. However, each valid flux
distribution defined by the extreme pathways can be uniquely
decomposed into themodes. It has been shown herein that it is
possible to utilize SVD in such a manner that the de-
composition yields insight to biological function.
This framework was subsequently applied to the analysis
of the extreme pathway matrices for amino acid production
in H. inﬂuenzae and H. pylori. The metabolic network for
amino acid production in H. pylori was characterized by
higher first fractional singular values and a lower effective
dimensional space in comparison to the results from H.
inﬂuenzae. These results are in agreement with previously
published analyses that demonstrated a much more restricted
metabolic potential for H. pylori than H. inﬂuenzae (Papin
et al., 2002a; Price et al., 2002a). Understanding and
characterizing the metabolic potential of pathogens like H.
pylori and H. inﬂuenzae can also lead to the targeting of an
organism’s weaknesses, important for therapeutic purposes
and metabolic engineering design.
The comparison of solution cones can be challenging
because cones differ in their dimensionality. Direct compar-
isons can only be made for cones of the same dimension and
with the same fluxes. SVD can be used to facilitate rough
comparisons between cones. The first mode describes the
direction of most variance within the cone. Thus, by
comparing the angle between the first mode of different
cones, a comparison can be made between the general
directions of the two cones. The first modes must contain the
same sets of fluxes to be compared directly. For this reason,
the comparisons made between the first modes of solution
cones were only made within the same organism and for the
production of one amino acid with all other allowable fluxes
being identical (i.e., the same stoichiometric matrix). Thus,
for these calculations we were able to make comparisons
between solution cones.
Subsequent modes may serve to further the understanding
of regulatory logic in metabolic networks. The subsequent
modes of the SVD characterize orthogonal pathways that
describe the variance in the flux space. An interpretation of
these modes will enable the characterization of the tradeoffs
in flux values that best reconstruct the solution space. The
subsequent modes identify key branch points in the network,
which are potential control points for regulation. Thus, these
subsequent modes can be thought of as finding key
regulatory modalities. They represent orthogonal directions
in the space, and thus they are uncoupled from each other in
a mathematical sense. However, biological systems are not
constrained by the need for orthogonal regulatory modalities.
Once the subsequent modes that best represent the solution
space (or a portion of the solution space that is of most
interest) are calculated, these modes can be transformed into
nonorthogonal, biologically meaningful vectors. A need
exists for the elucidation of optimal criteria for decoupling
these predicted regulatory modalities based upon biochem-
ical considerations, rather than by the mathematical
definition of orthogonality. The elucidation of the way in
which the subsequent modes describe cellular regulation
warrants further study, as does an investigation of the criteria
by which these subsequent modes can be transformed to
maximize insight into the regulation of biological systems.
Extreme pathways are becoming an important tool for the
analysis of metabolic networks. Flux balance analysis
(Edwards et al., 1999), kinetic theory (Reich and Sel’kov,
1981; Heinrich and Schuster, 1996), elementary modes
(Schuster et al., 2000), and metabolic control analysis (Fell,
1996) have yielded biologically important results. Extreme
pathway analysis generates a unique and minimal set of basis
vectors that circumscribe all possible steady-state flux
solutions of a metabolic network. As such, the understanding
and analysis of extreme pathways result in time-invariant,
systemic characterizations of the full capabilities of an
organism. SVD of extreme pathway matrices is a novel
application for reducing the dimensionality of these data sets
and providing succinct characterizations of the metabolic
solution space.
Taken together, the SVD of extreme pathway matrices has
led to interesting and important characterizations of the
properties of metabolic networks, and may potentially
provide clues to inherent systemic regulatory structures.
The results presented herein point to how emergent properties
can be elucidated from systemic in silico analyses. As the
amount of genomic data expands, approaches such as extreme
pathway analysis and the SVD of its resultant pathways will
lead to a systemic understanding of biological systems.
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